Q63-10170-23961 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-22
Registered in v-safe
2022-06-22
Dose 1 — Pfizer-BioNTech
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-29
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-06
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-13
Dose 2 — Pfizer-BioNTech
2022-07-27
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-03
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-10
Health check-in — day 28, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-08-17
Survey response — day 35, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Runny nose, cough

MedDRA releases: 2024-11 · check-in free text available
2022-08-17
Report sent to call center — day 35, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-08-18
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-08-24
Health check-in — day 42, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-09-14
Dose 3 — Pfizer-BioNTech
2022-09-15
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Poor · Fever · Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-09-16
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Poor · Fever · Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-09-17
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Poor · Fever · Irritability/crying, Loss of appetite · Be unable to work or attend school

Under 3 check-in
2022-09-18
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Poor · Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-09-19
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Nasal congestion — Feeling: Fair · Loss of appetite · Be unable to work or attend school

Free text: Nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-09-20
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Nasal congestion — Feeling: Fair · Loss of appetite · Be unable to work or attend school

Free text: Nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-09-21
Survey response — day 7, dose 3, under 3
MedDRA: Nasal congestion — Feeling: Poor · Be unable to work or attend school

Free text: Nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-09-28
Health check-in — day 14, dose 3, under 3
Feeling: Fair

Under 3 check-in
2022-10-05
Health check-in — day 21, dose 3, under 3
Feeling: Fair

Under 3 check-in
2022-10-12
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-21
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-26
Survey response — day 42, dose 3, under 3
MedDRA: Cough — Feeling: Poor · Be unable to work or attend school

Free text: Coughing

MedDRA releases: 2024-11 · check-in free text available
2022-12-14
Survey response — 3 months, dose 3, under 3
MedDRA: Cough, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Coughing, fever

MedDRA releases: 2024-11 · check-in free text available
2023-03-15
Health check-in — 6 months, dose 3, under 3
Feeling: Fair

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-22	Pfizer-BioNTech	No
2	2022-07-13	Pfizer-BioNTech	No
3	2022-09-14	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 35, dose 2, under 3

2022-08-17

Symptoms: Runny nose, cough

Release 12 (Under 3) — days 1–6 daily, dose 3, under 3

2022-09-19

Systemic reaction (other): Nasal congestion

2022-09-20

Systemic reaction (other): Nasal congestion

Release 12 (Under 3) — day 7, dose 3, under 3

2022-09-21

Systemic reaction (other): Nasal congestion

Release 12 (Under 3) — day 42, dose 3, under 3

2022-10-26

Symptoms: Coughing

Release 12 (Under 3) — 3 months, dose 3, under 3

2022-12-14

Symptoms: Coughing, fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SRO	Nasal congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release